119 related articles for article (PubMed ID: 1619496)
1. Cost effectiveness of work-site cholesterol screening and intervention programs.
Wilson MG; Edmunson J; DeJoy DM
J Occup Med; 1992 Jun; 34(6):642-9. PubMed ID: 1619496
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of work-site wellness programs for hypertension control, weight loss, and smoking cessation.
Erfurt JC; Foote A; Heirich MA
J Occup Med; 1991 Sep; 33(9):962-70. PubMed ID: 1744745
[TBL] [Abstract][Full Text] [Related]
3. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
[TBL] [Abstract][Full Text] [Related]
4. Using an ounce of prevention: does it reduce health care expenditures and reap pounds of profits? A study of the financial impact of wellness and health risk screening programs.
Phillips JF
J Health Care Finance; 2009; 36(2):1-12. PubMed ID: 20499716
[TBL] [Abstract][Full Text] [Related]
5. Examining the cost-effectiveness of cancer screening promotion.
Andersen MR; Urban N; Ramsey S; Briss PA
Cancer; 2004 Sep; 101(5 Suppl):1229-38. PubMed ID: 15316909
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hypercholesterolemia in a national worksite sample.
Wilson MG; Edmunson J
Am J Prev Med; 1991; 7(5):280-4. PubMed ID: 1790033
[TBL] [Abstract][Full Text] [Related]
8. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
Milani RV; Lavie CJ
Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of minimal contact education strategies for cholesterol change.
Gans KM; Burkholder GJ; Risica PM; Harrow B; Lasater TM
Ethn Dis; 2006; 16(2):443-51. PubMed ID: 17682247
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.
Kourbatova EV; Akovbyan VA; Chesson HW; Lytkina IN; Dmitriev GA; Tikhonova LI; Koubanova AA; Petukhova II; Latypova MF; Aboymova OA; Lewis JS; Ryan CA; Shakarishvili A
Sex Transm Dis; 2008 May; 35(5):453-60. PubMed ID: 18434940
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum cholesterol in employees after three years of multifactorial intervention.
Martínez-González MA; Bueno-Cavanillas A; Sánchez-Izquierdo F; García-Martín M; Delgado-Rodríguez M; Gálvez-Vargas R
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):40-8. PubMed ID: 9533233
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of the IMPACT worksite cholesterol reduction program.
Fielding JE; Mason T; Kinght K; Klesges R; Pelletier KR
Am J Prev Med; 1995; 11(2):120-3. PubMed ID: 7632447
[TBL] [Abstract][Full Text] [Related]
14. Brief interventions for at-risk drinking: patient outcomes and cost-effectiveness in managed care organizations.
Babor TF; Higgins-Biddle JC; Dauser D; Burleson JA; Zarkin GA; Bray J
Alcohol Alcohol; 2006; 41(6):624-31. PubMed ID: 17035245
[TBL] [Abstract][Full Text] [Related]
15. The cost of implementation of the Clinical Laboratory Improvement Amendments of 1988--the example of pediatric office-based cholesterol screening.
Tershakovec AM; Brannon SD; Bennett MJ; Shannon BM
Pediatrics; 1995 Aug; 96(2 Pt 1):230-4. PubMed ID: 7630675
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol, children, and heart disease: an analysis of alternatives.
Berwick DM; Cretin S; Keeler E
Pediatrics; 1981 Nov; 68(5):721-30. PubMed ID: 6796932
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of two self-care interventions to reduce disability associated with back pain.
Strong LL; Von Korff M; Saunders K; Moore JE
Spine (Phila Pa 1976); 2006 Jul; 31(15):1639-45. PubMed ID: 16816756
[TBL] [Abstract][Full Text] [Related]
19. Nurses' intervention in specific risk factors in high risk employees. An economic appraisal.
Chenoweth D
AAOHN J; 1989 Sep; 37(9):367-73. PubMed ID: 2505784
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
